Levels of serum cathepsin L and several glycosidases in patients operated for colorectal cancer

被引:8
|
作者
Sánchez-Martín, MM
Cabezas, JA
Ortega, S
García, J
García-Criado, FJ
Pina, J
Gómez-Alonso, A
机构
[1] Univ Salamanca, Fac Biol, Dept Bioquim & Biol Mol, Salamanca 37007, Spain
[2] Hosp Univ Salamanca, Dept Cirugia, Salamanca, Spain
关键词
colorectal cancer; cathepsin L; beta-galactosidase; alpha-L-fucosidase; sialic acid;
D O I
10.1016/S0304-3835(99)00078-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The activities of several glycosidases and cathepsin L were determined in the blood serum of a control group of ten healthy humans in comparison with a group (group I: 32 subjects) of preoperative colorectal cancer patients (1 week before surgical exeresis) and with another two groups: group II, comprising 18 operated subjects (1 week after surgery), and group III, of 15 operated subjects (4 months after surgery). All subjects were 48-88 years old. Both 'enzyme activity' and 'specific activity' determinations of serum beta-galactosidase, alpha-L-fucosidase and cathepsin L revealed peculiar profiles that differed from one another. Control values differed from those of some stages of the pathological groups, but not of others. These values were compared also with the levels of total, lipid- and glycoprotein-associated serum sialic acid. The usefulness of some assays (especially cathepsin L activity measurement) in the follow-up of the health status of humans operated for colorectal cancer is discussed. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [1] Evaluation of serum levels of cathepsin S among colorectal cancer patients
    Ghanadi, Koroush
    Ashorzadeh, Saber
    Aliyepoor, Asghar
    Anbari, Khatereh
    ANNALS OF MEDICINE AND SURGERY, 2022, 78
  • [2] Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma
    Veingerl, B
    WIENER KLINISCHE WOCHENSCHRIFT, 2001, 113 : 32 - 38
  • [3] Serum adipokine levels in colorectal cancer patients
    Ferroni, P.
    Roselli, M.
    Martini, F.
    Spila, A.
    Del Monte, G.
    Laudisi, A.
    Sini, V.
    Buonomo, O.
    Palmirotta, R.
    Guadagni, F.
    EJC SUPPLEMENTS, 2007, 5 (04): : 91 - 91
  • [4] SERUM LEPTIN LEVELS IN COLORECTAL CANCER PATIENTS
    Guadagni, F.
    Roselli, M.
    Spila, A.
    D'Alessandro, R.
    Lucci, I.
    Polce, L.
    Formica, V.
    Laudisi, A.
    Portarena, I.
    Palmirotta, R.
    Ferroni, P.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3304 - 3304
  • [5] Serum irisin levels in colorectal cancer patients
    Celik, Z.
    Baygutalp, N. K.
    Kilic, A. F.
    Tekin, S. B.
    Bakan, E.
    Gul, M. A.
    Yuce, N.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (04) : 2474 - 2479
  • [6] Increasing Cystatin C and Cathepsin B in Serum of Colorectal Cancer Patients
    Zhang, Jie
    He, Ping
    Zhong, Qi
    Li, Ke
    Chen, Dan
    Lin, Qing
    Liu, Weiwei
    CLINICAL LABORATORY, 2017, 63 (02) : 365 - 371
  • [7] Cathepsin X in serum from patients with colorectal cancer: relation to prognosis
    Vizin, Tjasa
    Christensen, Ib Jarle
    Nielsen, Hans Jorgen
    Kos, Janko
    RADIOLOGY AND ONCOLOGY, 2012, 46 (03) : 207 - 212
  • [8] Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer
    Schweiger, A
    Christensen, IJ
    Nielsen, HJ
    Sorensen, S
    Brünner, N
    Kos, J
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2004, 19 (04): : 289 - 294
  • [9] Assessment of serum granulysin and cathepsin-L levels in vitiligo patients
    Yazar, Cemre
    Akbayrak, Atiye
    Ozmen, Zeliha Cansel
    Kuyucu, Yunus Emre
    Sencan, Mehtap
    Kutlu, Omer
    Seckin, Havva Yildiz
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70 (05):
  • [10] Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients
    Vizin, Tjasa
    Christensen, Ib Jarle
    Wilhelmsen, Michael
    Nielsen, Hans Jorgen
    Kos, Janko
    BMC CANCER, 2014, 14